Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | APEX1 | P27695 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | ENO1 | P06733 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | STAT3 | P40763 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL44008 | 1.00 | POLB (0.41) | POLBALDH1A1TDP1HTTGAA | |
| SCHEMBL18072219 | 1.00 | POLB (0.41) | POLBALDH1A1TDP1HTTGAA | |
| Hydrochloric Acid SCHEMBL5234099 | 0.97 | POLB (0.40) | POLBALDH1A1TDP1HTTGAA | |
| Phosphoric Acid SCHEMBL5332637 | 0.91 | ENO1 (0.42) | POLBALDH1A1TDP1HTTGAA | |
| Maleic Acid SCHEMBL5334783 | 0.85 | HTT (0.40) | POLBALDH1A1HTTGAAHPGD | |
| Fumaric Acid SCHEMBL5334788 | 0.85 | HTT (0.40) | POLBALDH1A1HTTGAAHPGD | |
| Cadaverine Tartrate SCHEMBL5328579 | 0.83 | TSHR (0.39) | POLBALDH1A1HTTGAAHPGD | |
| SCHEMBL1260990 | 0.80 | POLB (0.37) | POLBALDH1A1TDP1CYP3A4TSHR | |
| SCHEMBL31289551 | 0.80 | ALDH1A1 (0.39) | POLBALDH1A1TDP1CYP3A4TSHR | |
| SCHEMBL3678309 | 0.78 | ALDH1A1 (0.39) | POLBALDH1A1TDP1CYP3A4TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 315 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10000492-B2 | Process for producing diazabicyclooctane derivative | MEIJI SEIKA PHARMA CO., LTD. (JP) | 2018-06-19 | — | — | US | claimed |
| US-10000491-B2 | Process for producing diazabicyclooctane derivative and intermediate thereof | MEIJI SEIKA PHARMA CO., LTD. (JP) | 2018-06-19 | — | — | US | claimed |
| US-20170283415-A1 | PROCESS FOR PRODUCING DIAZABICYCLOOCTANE DERIVATIVE | MEIJI SEIKA PHARMA CO., LTD. (JP) | 2017-10-05 | — | — | US | claimed |
| US-20160264573-A1 | PROCESS FOR PRODUCING DIAZABICYCLOOCTANE DERIVATIVE AND INTERMEDIATE THEREOF | MEIJI SEIKA PHARMA CO., LTD. (JP) | 2016-09-15 | — | — | US | claimed |
| EP-3050883-A1 | PRODUCTION METHOD FOR DIAZABICYCLOOCTANE DERIVATIVE AND INTERMEDIARY BODY THEREOF | Meiji Seika Pharma Co., Ltd. (JP) | 2016-08-03 | — | — | EP | claimed |
| EP-2705081-B1 | ACTIVATED OXYGEN SCAVENGING COMPOSITIONS FOR PLASTIC CONTAINERS | GRAHAM PACKAGING CO (US) | 2015-08-19 | — | — | EP | claimed |
| EP-2705081-A1 | ACTIVATED OXYGEN SCAVENGING COMPOSITIONS FOR PLASTIC CONTAINERS | Graham Packaging Company, L.P. (US) | 2014-03-12 | — | — | EP | claimed |
| WO-2012154379-A1 | ACTIVATED OXYGEN SCAVENGING COMPOSITIONS FOR PLASTIC CONTAINERS | GRAHAM PACKAGING COMPANY, L.P. (US) | 2012-11-15 | — | — | WO | claimed |
| US-20120283366-A1 | ACTIVATED OXYGEN SCAVENGING COMPOSITIONS FOR PLASTIC CONTAINERS | GRAHAM PACKAGING COMPANY, L.P. (US) | 2012-11-08 | — | — | US | claimed |
| EP-1340780-B1 | USE OF SELECTED METAL CATALYSTS FOR RING-OPENING POLYMERIZATION OF EPOXIDES | SANYO CHEMICAL IND LTD (JP) | 2010-07-21 | — | — | EP | claimed |
| US-6037477-A | CONTACTING AN ETHER WITH OXYGEN IN THE PRESENCE OF AN OXIDATION CATALYST TO PRODUCE ESTER OR ANHYDRIDE | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2000-03-14 | — | — | US | claimed |
| US-6020522-A | Process for producing aromatic hydroxycarboxylic acid derivatives | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2000-02-01 | — | — | US | claimed |
| US-5958821-A | EPOXIDATION OF AN ALKENE USING A CYCLIC N-HYDROXYIMIDE AND A COCATALYST OF A COMPOUND OF A GROUP 2A OR TRANSITION METAL USING OXYGEN; CATALYST SELECTIVITY; FREE OF PHOSPHO-VANADOMOLYBDIC ACID OR TETRAPHENYLPORPHYRINTOATO MANGANESE | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1999-09-28 | — | — | US | claimed |
| EP-0927711-A1 | ADAMANTANE DERIVATIVES AND PROCESS FOR PRODUCING THEM | Daicel Chemical Industries, Ltd. (JP) | 1999-07-07 | — | — | EP | claimed |
| EP-0897747-A1 | NITRATION OR CARBOXYLATION CATALYSTS | Daicel Chemical Industries, Ltd. (JP) | 1999-02-24 | — | — | EP | claimed |
| EP-0879812-A1 | Process for producing aromatic hydroxycarboxylic acid derivatives | Daicel Chemical Industries, Ltd. (JP) | 1998-11-25 | — | — | EP | claimed |
| EP-0878458-A1 | Oxidation process of ethers | Daicel Chemical Industries, Ltd. (JP) | 1998-11-18 | — | — | EP | claimed |
| EP-0878234-A2 | Oxygenation catalyst and process for producing a ketone using the same | Daicel Chemical Industries, Ltd. (JP) | 1998-11-18 | — | — | EP | claimed |
| EP-0824962-A1 | OXIDATION CATALYST SYSTEM AND PROCESS FOR OXIDATION WITH THE SAME | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1998-02-25 | — | — | EP | claimed |
| WO-1995025090-A1 | CYCLIC N-ALKENYLOXYIMIDES AND A METHOD FOR THE PREPARATION OF CYCLIC N-ALKENYLOXYIMIDES, THE CORRESPONDING CYCLIC N-ALKOXYIMIDES AND O-ALKOXYAMINES | DSM N.V. (NL) | 1995-09-21 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10000492-B2 | Process for producing diazabicyclooctane derivative | OGFOD1, HAAO, CLCN2 | POLB 931/4885ALDH1A1 311/4885TDP1 3730/4885 |
| US-20170283415-A1 | PROCESS FOR PRODUCING DIAZABICYCLOOCTANE DERIVATIVE | OGFOD1, HAAO, CLCN2 | POLB 931/4885ALDH1A1 311/4885TDP1 3730/4885 |
| US-20160264573-A1 | PROCESS FOR PRODUCING DIAZABICYCLOOCTANE DERIVATIVE AND INTERMEDIATE THEREOF | CLCN2, ODC1, KCNN4 | POLB 993/4885ALDH1A1 685/4885TDP1 3682/4885 |
| US-10000491-B2 | Process for producing diazabicyclooctane derivative and intermediate thereof | CLCN2, ODC1, KCNN4 | POLB 993/4885ALDH1A1 685/4885TDP1 3682/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.